一种非常强大的非核酸腺脱氨酶抑制剂:通过故意的杂化,通过故意的杂化来发现有效的药物
Tadashi Terasaka1, Takayoshi Kinoshita, Masako Kuno
1Medicinal Chemistry Research Laboratories, Basic Research Laboratories, and Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa-ku, Osaka 532-8514, Japan.
Journal of the American Chemical Society
|January 8, 2004
概括
研究人员迅速发现了一种强大的非核酸腺脱氨酶 (ADA) 抑制剂,该抑制剂通过将两个不同的分子结合起来. 这种药物发现方法加速了用于治疗开发的新化学实体的识别.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 氨酸脱氨酶 (ADA) 是免疫功能中的一个关键酶.
- 开发强大的ADA抑制剂是药物发现的关键目标.
- 现有的抑制剂可能在强度或特异性上有局限性.
研究的目的:
- 快速发现一种非常强大的非核酸抑制剂的腺氨酸脱氨酶 (ADA).
- 利用由结构生物学为基础的杂化策略.
- 展示一种有效的方法来识别新药候选药物.
主要方法:
- 合理的药物设计和随机查被用于识别初始抑制剂.
- 确定了牛ADA与抑制剂的晶体结构,以了解结合.
- 基于结构的药物设计用于杂化.
主要成果:
- 首个高强度非核酸ADA抑制剂被发现,其基值为7.7nM.
- 最初的微分子抑制剂揭示了新的结合部位和模式.
- 在两次代中的杂化产生了高度有效的化合物.
结论:
- 开发了一种快速有效的策略来发现强大的ADA抑制剂.
- 基于结构的杂化显著加速药物发现.
- 这种方法广泛适用于识别新的化学实体.
相关概念视频
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Enhanced Elimination of Poison
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...


